HOME ZACKS RESEARCH FUNDS PORTFOLIO BROKER RESEARCH MARKETS SCREENING EDUCATION SERVICES
Earnings    EPS Surprises    Mutual Funds    Options    My Account    Help    

PeopleandPicks.com is Zacks' Community Website
Find great stocks and great stock pickers in our online community. It's social, it's profitable and it's Free! Join the fun at PeopleandPicks.com
Quote:
Login Free Membership
Search:

Top Zacks Features
Free Membership
Premium Home
Zacks Rank
Equity Research
My Portfolio
Stock Screener
Profit Tracks
Mutual Funds
Options
Zacks Video
RSS Feed
Profit from the Pros

Subscription Services
Top 10 Stocks
Product Guide
Zacks Premium
Zacks Elite
Method for Trading
Chart Patterns Trader
Double Your Money
ETF Trader
Growth Trader
Options Trader
Small Cap Trader
Strategic Investor
Surprise Trader
Value Trader
Special Reports
Research Wizard

Zacks Premium
Get profitable stock
picks and timely
market advice in
Zacks.com`s Free
Daily Newsletter!

Free Registration

View the Archive

LH: Laboratory Corp Amer Hldgs - Stock Quote Enter Ticker:
 

QuoteEstimatesCharts Company ReportsNewsFinancials
  Quote |  Detailed Quotes |  Real Time |  Options Chain |  Greeks Montage

LABORATORY CORP AMER HLDGS (NYSE)
LH 70.15 0.01 (0.01%) Vol.  1,415,884 16:05 ET

Day Low - High N/A - 70.97
52wk Low - High 53.25 - 77.09
Avg Volume 1,190,794
Industry MED/DENTAL-SUPP
Market Cap 7.45 B
Div - Yield 0.00 - 0.00
PE (forward) 12.9
PEG Ratio 1.05
Current Year Est. 5.44
EPS Last Year 4.84
Detailed Quote


Premium Research: Stock Analysis

Zacks Rank

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.
Zacks Rank Definition Annualized Return
# 1Buy12%
# 2Strong Sell50.23%
# 3Hold14%
# 4Sell3.97%
# 5Hold1.85%
S&P50012.22%
Zacks Rank Education - Learn more about the Zacks Rank
Zacks Rank Home - All Zacks Rank resources in one place
Zacks Premium - The only way to get access to the Zacks Rank


Short-Term Rating 1-3 Months
PREMIUM
Zacks Recommendation

Zacks Recommendations are an excellent predictor of stock price movement over a 6+ month time frame. The recommendations come from the Zacks Equity Research group which combines the Zacks Rank with the insights from their team of over 50 equity analysts. The result is superior long term stock ratings.

The Zacks Recommendations are split into 3 groups: Outperform, Neutral and Underperform. When Zacks Premium members click on the recommendation it will launch them to the Zacks Equity Research report for the stock. More on these reports below.

Difference Between Zacks Rank and Zacks Recommendation
Zacks Equity Research Home
Zacks Premium - The only way to get access to Zacks Recommendations


Long-Term Rating 6+ Months
PREMIUM
Zacks Industry Rank

Which industries are set to outperform or underperform the market? You'll find the answer here. We have broken down all industries into over 200 classifications. Then ranked these industries using the most powerful indicator we know (the Zacks Rank). The higher the industry rank, the better the industry should perform in the future. Once you have found an attractive industry then check out the Rank in Industry to find the best stocks within the industry.

When Zacks Premium members click on the Zacks Industry Rank link they will see the full listing of industries and their current rankings.

About Zacks Industry Rank
Zacks Industry Rank - All current industry ranks.
Zacks Premium - The only way to get access to the Zacks Industry Rank

PREMIUM
Target Price

The Zacks Price Target provides you our expectation for a stocks share price in the next 6 months. These price targets are created by the Zacks Equity Research group to coincide with their recommendations that are also based on a 6 month time horizon.

Zacks Equity Research Home
Zacks Premium - The only way to get access to the Zacks Price Targets

PREMIUM
Equity Research Report

The Zacks Recommendations and Zacks Target Prices are just two of the valuable resources you'll find in the reports created by the Zacks Equity Research group. When Zacks Premium members click on this link they will taken to a page that gives them access to the Zacks Equity Research report for the stock.

Zacks Equity Research Home Zacks Premium - The only way to get access to Zacks Recommendations


Updated as of 12/29/2009
PREMIUM
Get all our stock ratings and recommendations with a Free Trial to Zacks Premium

Premium Research: Industry Analysis

Top Peers Ticker Zacks Rank
LABORATORY CORP AMER HLDGS LH PREMIUM
BIO REFERNC LAB BRLI PREMIUM
INVACARE CORP IVC PREMIUM
COOPER COS COO PREMIUM
See all MED/DENTAL-SUPP Peers

BROKERAGE RECOMMENDATIONS
Current ABR 2.11
ABR (Last Week) 2.11
# of Recs in ABR 18
Average Target Price 79.33
Industry Rank by ABR 128 out of 217
Rank in Industry 19 out of 33
More Brokerage Recommendations

Zacks Community PeopleAndPicks.com
Community Rating

PeopleAndPicks.com Community Stock Ratings

Rating Recommendation % of Stocks
5 stars Strong Buy 10%
4 stars Buy 20%
3 stars Hold 40%
2 stars Sell 20%
1 stars Strong Sell 10%
0 stars Not Rated  

We believe that a community of investors working together can create a superior stock rating system. Some call this "collective intelligence". Or simply...together we can beat the market!

A stock's Community Rating is calculated based on the aggregate input of the PeopleAndPicks Community. The proportion of buy to sell ratings, recency of analysis, and the average score of the users who rate it favorably all factor into a score of one to five stars.


How do you rate LH?
Buy
Sell
Find out what the Zacks Community
thinks of LH at PeopleAndPicks.com

NYSE data is at least 20 minutes delayed.
NASDAQ data is at least 15 minutes delayed.

 Interactive Java Charting
 Comparative Chart



 
ZACKS COMMENTARY FOR LH
Zacks Equity Research: Report for LH
Dec 29, 2009
Zacks Blog: Lab Corp Beats Estimates
Oct 22, 2009
Zacks Blog: Monogram Deal Inches Forward
Jul 21, 2009
Zacks Blog: LabCorp to Buy Monogram
Jul 07, 2009
Zacks Blog: Bayer Deal Not Enough for Celera
Jun 30, 2009
Zacks Blog: Zacks Analyst Blog Highlights: LabCorp, Monogram Biosciences, Inc., Pfizer, Quest Diagnostics and Myriad Genetics
Jun 24, 2009
Zacks Blog: Monogram Acquired by LabCorp
Jun 23, 2009
Zacks Blog: LH Tops Q4 by a Penny
Feb 12, 2009
More Zacks Commentary
NEWS
Quest Down; But Is Market Diagnosis Right? - TheStreet.com
Jan 25, 2010
SmarTrend research report available on Laboratory Corp of America Holdings (NYSE:LH)
Jan 20, 2010
BiomedReports: News and FDA Updates for LabCorp (NYSE:LH), Maxygen (Nasdaq:MAXY), Medidata (NASDAQ:MDSO)
Jan 20, 2010
LabCorp is Scheduled to Present at the Jefferies 2010 Global Healthcare Services Conference
Jan 19, 2010
Laboratory Corp of America Holdings Bullish Moving Average Crossover Alert (LH)
Jan 13, 2010
Laboratory Corp of America Holdings: The Trend Continues Up (LH)
Jan 11, 2010
Conversion Right Triggered for LabCorp's Zero Coupon Convertible Subordinated Notes Due 2021
Jan 05, 2010
Laboratory Corp of America Holdings Up 10.3% Since SmarTrend's Buy Recommendation
Dec 23, 2009
More News
EARNINGS ESTIMATES
  This Quarter
12/2009
Next Quarter
03/2010
This Year
12/2009
Next Year
12/2010
Average Estimate 1.15 1.32 4.89 5.44
Number of Estimates 19 13 19 19
Low Estimates 1.11 1.28 4.86 5.17
High Estimate 1.21 1.38 4.95 5.60
Year Ago EPS 1.10 1.22 4.61 4.89
EPS Growth 4.31% 8.01% 6.05% 11.25%

More Estimates

COMPANY DESCRIPTION
Laboratory Corporation of America Holdings, is one of the largest independent clinical laboratory company's in the United States. Through a national network of laboratories, the company offers different clinical laboratory tests which are used by the medical profession in routine testing, patient diagnosis, and in the monitoring and treatment of disease.

Full Company Report
FINANCIALS
EPS TTM 4.84
Sales 4505.2
Net Income 518.7
Price/Earnings 14.49
Price/Book 3.74
Price/Cash Flow 10.7
Price/Sales 1.6


More Financials

 
About Zacks | Advertise | Affiliate | Media | Careers | Contact Us | Help
Disclaimer | Privacy Policy | Sitemap
NYSE and AMEX data is at least 20 minutes delayed.  NASDAQ data is at least 15 minutes delayed.
Copyright 2010 Zacks Investment Research